Clinical Trial Update: Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A phase 2 trial of oxaliplatin, capecitabine, and bevacizumab as first-line therapy for advanced colorectal cancer has completed. Results from the study have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Southern California | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-01-15